Frank X. Leonard, EVP, President, Novocure Oncology at NovoCure Ltd (NVCR), sold 58,513 shares at $17.22 ($1.0M) on 2025-06-02, disclosed to the SEC on 2025-06-04.
Scheduled sale ($1.0M) by EVP, President, Novocure Oncology under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.22 | 21,717 | $374K | 36.6% |
| 2 | $17.22 | 21,717 | $374K | 36.6% |
| 3 | $17.99 | 6,600 | $119K | 11.6% |
| 4 | $17.99 | 6,600 | $119K | 11.6% |
| 5 | $19.01 | 1,879 | $36K | 3.5% |
| Total | $17.45 avg | 58,513 |
| $1.0M |
| 100% |
| Filing → |
| NVCR | SELL | 2026-03-03 | $231K | — | Filing → |
| NVCR | SELL | 2025-03-04 | $47K | — | Filing → |
| NVCR | SELL | 2025-03-03 | $552K | — | Filing → |